Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,968 | -59,437 | -30,788 | -16,868 | -7,886 |
| Depreciation Amortization | 730 | 776 | 483 | 321 | 162 |
| Accounts payable and accrued liabilities | 1,869 | 8,567 | 1,114 | 1,722 | 501 |
| Other Working Capital | 2,200 | 5,112 | 1,007 | 1,640 | 372 |
| Other Operating Activity | 1,776 | -1,526 | 1,712 | -1,401 | -437 |
| Operating Cash Flow | $-18,393 | $-46,508 | $-26,472 | $-14,586 | $-7,288 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -132,186 | -44,500 | N/A | N/A | N/A |
| PPE Investments | -9 | -1,161 | -438 | -282 | -211 |
| Purchase Of Investment | 3,820 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-128,375 | $-45,661 | $-438 | $-282 | $-211 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 9,936 | 9,936 | 9,936 | 9,936 |
| Debt Repayment | N/A | -10,000 | N/A | N/A | N/A |
| Common Stock Issued | 157,250 | 246,418 | 247,478 | 0 | N/A |
| Other Financing Activity | 0 | 134,336 | 134,470 | 1,972 | 1,972 |
| Financing Cash Flow | $157,250 | $380,690 | $391,884 | $11,908 | $11,908 |
| Beginning Cash Position | 303,153 | 14,632 | 14,632 | 14,632 | 14,632 |
| End Cash Position | 313,635 | 303,153 | 379,606 | 11,672 | 19,041 |
| Net Cash Flow | $10,482 | $288,521 | $364,974 | $-2,960 | $4,409 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,393 | -46,508 | -26,472 | -14,586 | -7,288 |
| Capital Expenditure | -9 | -1,161 | -438 | -282 | -211 |
| Free Cash Flow | -18,402 | -47,669 | -26,910 | -14,868 | -7,499 |